BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 18382208)

  • 1. Left ventricular assist device-induced molecular changes in the failing myocardium.
    Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
    Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
    Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
    Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments.
    Margulies KB
    J Card Fail; 2002 Dec; 8(6 Suppl):S500-5. PubMed ID: 12555165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
    Klotz S; Jan Danser AH; Burkhoff D
    Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
    Wohlschlaeger J; Schmitz KJ; Palatty J; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):37-43. PubMed ID: 17198778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device.
    Madigan JD; Barbone A; Choudhri AF; Morales DL; Cai B; Oz MC; Burkhoff D
    J Thorac Cardiovasc Surg; 2001 May; 121(5):902-8. PubMed ID: 11326233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
    Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterotopic transplantation as a model to study functional recovery of unloaded failing hearts.
    Tevaearai HT; Walton GB; Eckhart AD; Keys JR; Koch WJ
    J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1149-56. PubMed ID: 12447181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
    Matsumiya G; Monta O; Fukushima N; Sawa Y; Funatsu T; Toda K; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):699-704. PubMed ID: 16153916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling.
    Milting H; Jacob M; Kassner A; Heimann P; Mannherz HG; Becker G; Meyer HE; Böthig D; Arusoglu L; Morshuis M; Körfer R; El Banayosy A
    J Heart Lung Transplant; 2004 Apr; 23(4):396-404. PubMed ID: 15063398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart.
    Wohlschlaeger J; Levkau B; Brockhoff G; Schmitz KJ; von Winterfeld M; Takeda A; Takeda N; Stypmann J; Vahlhaus C; Schmid C; Pomjanski N; Böcking A; Baba HA
    Circulation; 2010 Mar; 121(8):989-96. PubMed ID: 20159834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular changes after left ventricular assist device support for heart failure.
    Birks EJ
    Circ Res; 2013 Aug; 113(6):777-91. PubMed ID: 23989719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery.
    Burkhoff D; Klotz S; Mancini DM
    J Card Fail; 2006 Apr; 12(3):227-39. PubMed ID: 16624689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
    Klotz S; Naka Y; Oz MC; Burkhoff D
    J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar left and right ventricular sarcomere structure after support with a left ventricular assist device suggests the utility of right ventricular biopsies to monitor left ventricular reverse remodeling.
    de Jonge N; Lahpor JR; van Wichen DF; Kirkels H; Gmelig-Meyling FH; van den Tweel JG; Doevendans PA; de Weger RA
    Int J Cardiol; 2005 Feb; 98(3):465-70. PubMed ID: 15708181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.
    Hall JL; Birks EJ; Grindle S; Cullen ME; Barton PJ; Rider JE; Lee S; Harwalker S; Mariash A; Adhikari N; Charles NJ; Felkin LE; Polster S; George RS; Miller LW; Yacoub MH
    Eur Heart J; 2007 Mar; 28(5):613-27. PubMed ID: 17132651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse remodeling during long-term mechanical unloading of the left ventricle.
    Drakos SG; Terrovitis JV; Anastasiou-Nana MI; Nanas JN
    J Mol Cell Cardiol; 2007 Sep; 43(3):231-42. PubMed ID: 17651751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.
    Soderlund KA; Chivukula RR; Russell SD; Conte JV; Mudd JO; Halushka MK
    Cardiovasc Pathol; 2009; 18(4):217-22. PubMed ID: 18706833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data.
    Morley D; Litwak K; Ferber P; Spence P; Dowling R; Meyns B; Griffith B; Burkhoff D
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):21-8. PubMed ID: 17198776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.